DJIA 18,041.54 -190.48 -1.04%
NASDAQ 5,032.75 -56.61 -1.11%
S&P 500 2,104.20 -21.86 -1.03%
market minute promo

235.31 -2.22 (-0.93%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

VRX $235.31 -0.93%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $237.97
Previous Close $237.53
Daily Range $233.17 - $239.03
52-Week Range $106.00 - $239.03
Market Cap $80.6B
P/E Ratio 80.52
Dividend (Yield) $0.00 (0.0%)
Volume 2,044,177
Average Daily Volume 1,792,775
Current FY EPS $2.96




Drug Makers

Valeant Pharmaceuticals (VRX) Description

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology. Website:

News & Commentary

Here's What Bill Ackman Has Been Buying and Selling

Bill Ackman's Allergan defeat was kind of a victory.

Pharmacyclics' Imbruvica Gets CHMP's Nod for Full Approval - Analyst Blog

Merck KGaA-BioMarin's Kuvan may Undergo Label Update - Analyst Blog

Bristol-Myers' Opdivo Gets Positive Opinion from CHMP - Analyst Blog

Bristol-Myers' Opdivo Gets Positive Opinion from CHMP - Analyst Blog

Novo Nordisk's Saxenda Delays Onset of Type II Diabetes - Analyst Blog

Billionaire George Soros Just Sold These 3 Stocks: Should You?

The Soros Fund Management sold Kite Pharma, Valeant Pharmaceuticals, and Teva Pharmaceutical Industries Ltd. in the first quarter. Should you follow in its footsteps?

Ampio Pharmaceuticals Shoots up on Positive Optina Data - Analyst Blog

Alnylam's Cardiac Amyloidosis Drug Gets Orphan Status - Analyst Blog

Hedge Funds Buy Actavis, Valeant. ETFs Join The Party

Valeant CEO: Healthcare Sector A 'Bit Of A Bubble'

See More VRX News...

VRX's Top Competitors

VRX $235.31 (-0.93%)
Current stock: VRX
JNJ $100.82 (-0.52%)
Current stock: JNJ
NVS $101.81 (-1.96%)
Current stock: NVS
RHHBY $36.24 (-1.62%)
Current stock: RHHBY